Using the mask – Do’s and Don’ts in the COVID-19 scenario

2020 ◽  
Vol 11 (SPL1) ◽  
pp. 901-906
Author(s):  
Sherly Deborah G ◽  
Archana R ◽  
Harini Narayanam

A face mask is a loose-fitting, disposable outfit that acts as a physical barrier between the mouth and nose of an individual and the potential pollutants in the surrounding environment. COVID-19 which is also called as 2019-nCov is caused by the novel coronavirus and it is spread by the salivary droplets or nasal discharge released when an infected person coughs or sneezes. In the current COVID -19 scenario, the face mask is designed to ameliorate the prevention of airborne transmission of the novel coronavirus. The use of face mask is competent only when the other personal preventive measures are ideally pursued. The effectiveness of the use of face mask depends strongly on the do’s and don’ts which has to followed while wearing a face mask. The purpose of this study is to analyze and summarize the published literature associated with the types, usage, risks, limitations, disposal and reusability of face mask. The availability of medication and treatment options are sparse and the development of vaccines for COVID-19 is going to take a longer time. Hence the most effective strategy to curb the spread of the disease is by the judicious use of face mask along with other personal protective measures.

2020 ◽  
Author(s):  
Ramzi Fatfouta ◽  
Yulia Oganian

Face masks play a pivotal role in the control and prevention of respiratory diseases, such as the novel coronavirus (COVID-19). Despite their widespread use, it is not known how face masks affect human social interaction. In this behavioral economics study (N = 475), we examined how mask-wearing modulates individuals’ likelihood of acceptance of unfair monetary offers in an iterated social exchange. Overall, participants accepted more offers, including more unfair offers, from mask-wearing opponents than from opponents without a mask. This effect was enhanced when participants ascribed more altruistic motives to their interaction partner. Importantly, this pattern of results was only present for surgical face masks, but not when a non-medical cloth face covering was used. This is the first study to uncover a new phenomenon, the face-mask effect, in which face masks can alter human social behavior.


2021 ◽  
Vol 9 (10) ◽  
pp. 225-226
Author(s):  
Chanchal Chaukrayat ◽  
G. Ramalakshmi ◽  
Renjith Thomas

Coronavirus disease 2019 (COVID-19) is a contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first known case was identified in Wuhan, China in December 2019. The disease has since spread worldwide, leading to an ongoing pandemic.After COVID-19 infection, most people form adequate antibodies which prevents them from contracting the virus again. Nonetheless, its an unknown territory for the medical practitioners across the world, as to how long can that immunity stand. Cases where patients had the novel coronavirus again, have been reported too. More in this way, for individuals who are at a high risk of reinfection are either old or dont take enough preventive measures to additionally protect their immune system which makes post-COVID care important for them. While the standard laws of staying safe suggest everyone to cover their face with a face mask, wash hands regularly and practice social distancing.


2021 ◽  
pp. 0272989X2110030
Author(s):  
Serin Lee ◽  
Zelda B. Zabinsky ◽  
Judith N. Wasserheit ◽  
Stephen M. Kofsky ◽  
Shan Liu

As the novel coronavirus (COVID-19) pandemic continues to expand, policymakers are striving to balance the combinations of nonpharmaceutical interventions (NPIs) to keep people safe and minimize social disruptions. We developed and calibrated an agent-based simulation to model COVID-19 outbreaks in the greater Seattle area. The model simulated NPIs, including social distancing, face mask use, school closure, testing, and contact tracing with variable compliance and effectiveness to identify optimal NPI combinations that can control the spread of the virus in a large urban area. Results highlight the importance of at least 75% face mask use to relax social distancing and school closure measures while keeping infections low. It is important to relax NPIs cautiously during vaccine rollout in 2021.


2021 ◽  
pp. 21-34
Author(s):  
PU JINGXIN

Abstract: The danger of the novel coronavirus has not yet come to an end, and new variants have begun to attack the world. What philosophy should humankind’s strategy be based on when human society as a group is fighting against Covid-19, as the pandemic ravages the world? Unfortunately, political leaders of various countries have failed to achieve the overall awareness of attacking the pandemic for a shared future for mankind so far. In the face of the pandemic, mankind as a whole urgently needs to break through the narrow nation-oriented ideology of seeking only self-protection. The International Community should establish a new type of international cooperation featuring the concept of harmony of "all things under heaven as a unity". The international relations system dominated by the power ofwestern discourse is now in a bottleneck. The main aim of this article is to study the ancient Chinese wisdom of "the Unity of Man and Heaven" philosophy and build a global harmonious community. The author argues that the “export” of the aforementioned wisdom must be a priority for Chinese scholars. Keywords: Tao; Unity of Man and Heaven; Novel Coronavirus; Anthropocentrism; Harmony.


2021 ◽  
Vol 4 (11) ◽  
pp. RV1-RV5
Author(s):  
Najmus Sahar ◽  
Pradeep Tangade ◽  
Vikas Singh ◽  
Surbhi Priyadarshini ◽  
Debashis Roy

The novel coronavirus outbreak is a contagious disease affecting the countries around the world. The quick advancing nature of pandemic has gripped the entire community making it a public health emergency. Infection control preventive measures are necessary to prevent it from further spreading. Medical practitioners, health care workers and Dentists are at high risk of acquiring and transmission of infection. The virus transmission occurs through respiratory tract, aerosols and droplets. Clinical manifestations of virus vary from mild to severe sickness. This review article mainly emphasizes on all the information collected to date on the virus, and future recommendations for dental settings to manage the further spread of this virus.


Pathogens ◽  
2020 ◽  
Vol 9 (3) ◽  
pp. 231 ◽  
Author(s):  
Firas A. Rabi ◽  
Mazhar S. Al Zoubi ◽  
Ghena A. Kasasbeh ◽  
Dunia M. Salameh ◽  
Amjad D. Al-Nasser

In December 2019, a cluster of fatal pneumonia cases presented in Wuhan, China. They were caused by a previously unknown coronavirus. All patients had been associated with the Wuhan Wholefood market, where seafood and live animals are sold. The virus spread rapidly and public health authorities in China initiated a containment effort. However, by that time, travelers had carried the virus to many countries, sparking memories of the previous coronavirus epidemics, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), and causing widespread media attention and panic. Based on clinical criteria and available serological and molecular information, the new disease was called coronavirus disease of 2019 (COVID-19), and the novel coronavirus was called SARS Coronavirus-2 (SARS-CoV-2), emphasizing its close relationship to the 2002 SARS virus (SARS-CoV). The scientific community raced to uncover the origin of the virus, understand the pathogenesis of the disease, develop treatment options, define the risk factors, and work on vaccine development. Here we present a summary of current knowledge regarding the novel coronavirus and the disease it causes.


2020 ◽  
Vol 95 (6) ◽  
pp. 360-363
Author(s):  
Minyoung Sim

The novel coronavirus disease 2019 (COVID-19) pandemic has spread across the world, reducing social interactions and causing substantial psychological distress and economic losses. This review summarizes the psychological effects of the COVID-19 pandemic in terms of uncertainty, the loss of autonomy associated with preventive measures, and secondary stressors such as potential future economic losses.


2021 ◽  
Vol VI (I) ◽  
pp. 1-9
Author(s):  
Naiha Tahir ◽  
Ayema Rehman ◽  
Muhammad Zain ◽  
Mubashir Rehman

The novel Coronavirus knew as Covid 19 or SARS-CoV-2, is a newly discovered virus responsible for the huge global pandemic infecting the human race at a deadly pace. This is an RNA enveloped virus that targets the human respiratory system severely while damaging other major systems. Covid 19 pandemic is similar to the severe acute respiratory syndrome related coronavirus (SARS-CoV) endemic and the Middle East Respiratory Syndrome Coronavirus (MERS-CoV), but this one is spreading at a fire-speed. The outbreak was known as pneumonia in the beginning; however, it became a threat later on, owing to its high contagion rate. The origin of this virus was sought to be from the seafood wholesale market, very popular in the city of Wuhan. This review has been put together to overview the disease, its etiology, clinical features and treatment methods. The focal point of this review is to highlight the current management of this disease.


2021 ◽  
Vol 4 (4) ◽  
pp. 311-323
Author(s):  
Venkataramana Kandi ◽  
Tarun Kumar Suvvari ◽  
Sabitha Vadakedath ◽  
Vikram Godishala

Because of the frequent emergence of novel microbial species and the re-emergence of genetic variants of hitherto known microbes, the global healthcare system, and human health has been thrown into jeopardy. Also, certain microbes that possess the ability to develop multi-drug resistance (MDR) have limited the treatment options in cases of serious infections, and increased hospital and treatment costs, and associated morbidity and mortality. The recent discovery of the novel Coronavirus (n-CoV), the Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) that is causing the CoV Disease-19 (COVID-19) has resulted in severe morbidity and mortality throughout the world affecting normal human lives. The major concern with the current pandemic is the non-availability of specific drugs and an incomplete understanding of the pathobiology of the virus. It is therefore important for pharmaceutical establishments to envisage the discovery of therapeutic interventions and potential vaccines against the novel and MDR microbes. Therefore, this review is attempted to update and explore the current perspectives in microbes, clinical research, drug discovery, and vaccine development to effectively combat the emerging novel and re-emerging genetic variants of microbes.


Author(s):  
Madhusmita Mohanty Mohapatra ◽  
Manju Rajaram ◽  
Dharm Prakash Dwivedi ◽  
Vishnukant Govindraj ◽  
Pratap Upadhya

Severe acute respiratory syndrome- coronavirus-2 (SARS-CoV-2) which emerged in Wuhan initially as pneumonia of unknown origin in December 2019, later spread to whole world and became pandemic on 11th March, 2020. Many drugs have been proposed but are backed without clinical evidence. Scientific bodies are in the row to discover a reliable vaccine and effective drugs against the novel coronavirus. Many antiviral and anti-parasitic drugs which were thought to have some effect on Coronavirus disease 2019 (COVID-19) have been tried during the crisis but none have shown concrete evidence of action. Randomized clinical trials on the repurposed drugs are now registered under clinical trial registry to look at the safety profile and efficacy of the drugs to be used against SARS-CoV-2. Many meta-analyses are being conducted worldwide to frame evidence for the fight against this novel coronavirus. We are providing below a review of various drugs that have been tried for treatment of COVID-19 as well as different clinical trials which are underway.


Sign in / Sign up

Export Citation Format

Share Document